Finding an Opportunity to Advance Pharmacy Practice During a Pandemic
June 30th 2021The COVID-19 pandemic has led to significant innovation, which presents a unique opportunity for pharmacists to advance pharmacy practice by serving as the integral drug monitoring experts of the health care team.
Read More
Study: Eating Patterns Could Affect Risk of Heart Disease Mortality
June 30th 2021The research concluded that eating starchy snacks after meals and eating a Western-style lunch containing refined grains, cheese, and cured meat elevates the risk of dying from heart disease and other illnesses.
Read More
The Future of Pharmaceuticals and the FDA Pipeline
June 30th 2021Chad Landmon, attorney and chair of Axinn’s Intellectual Property and FDA Practice Groups, discusses upcoming clinical trials on COVID-19 booster shots, the possibility of cancer vaccines, and the future of pharmaceuticals and FDA approvals.
Watch
Gilead Submits New Drug Application for Lenacapavir for the Treatment of HIV
June 30th 2021Lenacapavir was granted Breakthrough Therapy Designation in May 2019 and is a potential first-in-class capsid inhibitor for the treatment of HIV-1 infection without overlapping resistance with any currently approved antiretroviral therapy.
Read More
Key Events in the FDA Pipeline During COVID-19
June 29th 2021Pharmacy Times spoke with Chad Landmon, attorney and chair of Axinn’s Intellectual Property and FDA Practice Groups, about key events in the FDA pipeline, such as Emergency Use Authorizations during COVID-19 and the future of narrowed approvals.
Watch